Literature DB >> 10671871

Unilateral pedal lymphography in patients with filarial chyluria.

S Koga1, Y Nagata, Y Arakaki, M Matsuoka, C Ohyama.   

Abstract

OBJECTIVE: To evaluate the usefulness of unilateral pedal lymphography in patients with filarial chyluria. PATIENTS AND METHODS: Of 114 patients with filarial chyluria, all underwent lymphography (unilateral pedal in 106) and 55 underwent selective ureteric sampling for chyle.
RESULTS: Unilateral pedal lymphography in the 106 patients detected lymphaticorenal fistulae (LRF) in 104 (98%). Lymphatic crossover was seen in all 106 patients, from the second sacral segment to the first lumbar segment. The most frequent crossover site was at the L5 level (87%). There was complete correlation between the side of LRF and the side of chyluria as assessed by selective ureteric sampling.
CONCLUSION: Unilateral pedal lymphography can detect LRF via lymphatic crossover even when it is on the opposite side from that injected with contrast agent. The advantages of unilateral lymphography over bilateral procedures are that it is easy to identify crossover channels, and the discomfort for the patient is reduced because there are fewer incisions and it is quicker. Unilateral lymphography is recommended as the initial method when lymphography is indicated in filarial chyluria.

Entities:  

Mesh:

Year:  2000        PMID: 10671871     DOI: 10.1046/j.1464-410x.2000.00400.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  2 in total

1.  Unilateral pedal lymphangiography with non-contrast computerized tomography is valuable in the location and treatment decision of idiopathic chylothorax.

Authors:  Ding-Yi Liu; Yuan Shao; Jian-Xin Shi
Journal:  J Cardiothorac Surg       Date:  2014-01-07       Impact factor: 1.637

2.  Unilateral pedal lymphangiography plus computed tomography angiography for location of persistent idiopathic chyle leakage not detectable by ordinary contrast computed tomography.

Authors:  Dingyi Liu; Boke Liu; Weimu Xia; Qi Tang; Haidong Wang; Jian Wang; Yanfeng Zhou; Jiashun Yu; Wenmin Li; Mingwei Wang; Wenlong Zhou; Sang Hu; Yuan Shao
Journal:  BMC Urol       Date:  2018-02-06       Impact factor: 2.264

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.